Human Single-Cell Multi-Omics Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1551615 No. of Pages: 66 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Human Single-cell multi-omics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis.
This report aims to provide a comprehensive presentation of the global market for Human Single-Cell Multi-Omics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Single-Cell Multi-Omics. This report contains market size and forecasts of Human Single-Cell Multi-Omics in global, including the following market information:
Global Human Single-Cell Multi-Omics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Human Single-Cell Multi-Omics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Single-Cell Transcriptomics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Single-Cell Multi-Omics include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Single-Cell Multi-Omics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Single-Cell Multi-Omics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Human Single-Cell Multi-Omics Market Segment Percentages, by Type, 2022 (%)
Single-Cell Transcriptomics
Single-Cell Genomics
Single-Cell Proteomics
Global Human Single-Cell Multi-Omics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Human Single-Cell Multi-Omics Market Segment Percentages, by Application, 2022 (%)
Clinical Research
Translational Research
Synthetic Biology
Global Human Single-Cell Multi-Omics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Human Single-Cell Multi-Omics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Single-Cell Multi-Omics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Single-Cell Multi-Omics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Single-Cell Multi-Omics, market overview.
Chapter 2: Global Human Single-Cell Multi-Omics market size in revenue.
Chapter 3: Detailed analysis of Human Single-Cell Multi-Omics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Single-Cell Multi-Omics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Human Single-Cell Multi-Omics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Single-Cell Multi-Omics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Single-Cell Multi-Omics Overall Market Size
2.1 Global Human Single-Cell Multi-Omics Market Size: 2022 VS 2029
2.2 Global Human Single-Cell Multi-Omics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Single-Cell Multi-Omics Players in Global Market
3.2 Top Global Human Single-Cell Multi-Omics Companies Ranked by Revenue
3.3 Global Human Single-Cell Multi-Omics Revenue by Companies
3.4 Top 3 and Top 5 Human Single-Cell Multi-Omics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Single-Cell Multi-Omics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Single-Cell Multi-Omics Players in Global Market
3.6.1 List of Global Tier 1 Human Single-Cell Multi-Omics Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Single-Cell Multi-Omics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Single-Cell Multi-Omics Market Size Markets, 2022 & 2029
4.1.2 Single-Cell Transcriptomics
4.1.3 Single-Cell Genomics
4.1.4 Single-Cell Proteomics
4.2 By Type - Global Human Single-Cell Multi-Omics Revenue & Forecasts
4.2.1 By Type - Global Human Single-Cell Multi-Omics Revenue, 2018-2023
4.2.2 By Type - Global Human Single-Cell Multi-Omics Revenue, 2024-2029
4.2.3 By Type - Global Human Single-Cell Multi-Omics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Single-Cell Multi-Omics Market Size, 2022 & 2029
5.1.2 Clinical Research
5.1.3 Translational Research
5.1.4 Synthetic Biology
5.2 By Application - Global Human Single-Cell Multi-Omics Revenue & Forecasts
5.2.1 By Application - Global Human Single-Cell Multi-Omics Revenue, 2018-2023
5.2.2 By Application - Global Human Single-Cell Multi-Omics Revenue, 2024-2029
5.2.3 By Application - Global Human Single-Cell Multi-Omics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Human Single-Cell Multi-Omics Market Size, 2022 & 2029
6.2 By Region - Global Human Single-Cell Multi-Omics Revenue & Forecasts
6.2.1 By Region - Global Human Single-Cell Multi-Omics Revenue, 2018-2023
6.2.2 By Region - Global Human Single-Cell Multi-Omics Revenue, 2024-2029
6.2.3 By Region - Global Human Single-Cell Multi-Omics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Human Single-Cell Multi-Omics Revenue, 2018-2029
6.3.2 US Human Single-Cell Multi-Omics Market Size, 2018-2029
6.3.3 Canada Human Single-Cell Multi-Omics Market Size, 2018-2029
6.3.4 Mexico Human Single-Cell Multi-Omics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Human Single-Cell Multi-Omics Revenue, 2018-2029
6.4.2 Germany Human Single-Cell Multi-Omics Market Size, 2018-2029
6.4.3 France Human Single-Cell Multi-Omics Market Size, 2018-2029
6.4.4 U.K. Human Single-Cell Multi-Omics Market Size, 2018-2029
6.4.5 Italy Human Single-Cell Multi-Omics Market Size, 2018-2029
6.4.6 Russia Human Single-Cell Multi-Omics Market Size, 2018-2029
6.4.7 Nordic Countries Human Single-Cell Multi-Omics Market Size, 2018-2029
6.4.8 Benelux Human Single-Cell Multi-Omics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Human Single-Cell Multi-Omics Revenue, 2018-2029
6.5.2 China Human Single-Cell Multi-Omics Market Size, 2018-2029
6.5.3 Japan Human Single-Cell Multi-Omics Market Size, 2018-2029
6.5.4 South Korea Human Single-Cell Multi-Omics Market Size, 2018-2029
6.5.5 Southeast Asia Human Single-Cell Multi-Omics Market Size, 2018-2029
6.5.6 India Human Single-Cell Multi-Omics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Human Single-Cell Multi-Omics Revenue, 2018-2029
6.6.2 Brazil Human Single-Cell Multi-Omics Market Size, 2018-2029
6.6.3 Argentina Human Single-Cell Multi-Omics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Single-Cell Multi-Omics Revenue, 2018-2029
6.7.2 Turkey Human Single-Cell Multi-Omics Market Size, 2018-2029
6.7.3 Israel Human Single-Cell Multi-Omics Market Size, 2018-2029
6.7.4 Saudi Arabia Human Single-Cell Multi-Omics Market Size, 2018-2029
6.7.5 UAE Human Single-Cell Multi-Omics Market Size, 2018-2029
7 Human Single-Cell Multi-Omics Companies Profiles
7.1 10x Genomics
7.1.1 10x Genomics Company Summary
7.1.2 10x Genomics Business Overview
7.1.3 10x Genomics Human Single-Cell Multi-Omics Major Product Offerings
7.1.4 10x Genomics Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.1.5 10x Genomics Key News & Latest Developments
7.2 1CellBio
7.2.1 1CellBio Company Summary
7.2.2 1CellBio Business Overview
7.2.3 1CellBio Human Single-Cell Multi-Omics Major Product Offerings
7.2.4 1CellBio Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.2.5 1CellBio Key News & Latest Developments
7.3 BGI Genomics
7.3.1 BGI Genomics Company Summary
7.3.2 BGI Genomics Business Overview
7.3.3 BGI Genomics Human Single-Cell Multi-Omics Major Product Offerings
7.3.4 BGI Genomics Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.3.5 BGI Genomics Key News & Latest Developments
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Company Summary
7.4.2 Bio-Rad Laboratories Business Overview
7.4.3 Bio-Rad Laboratories Human Single-Cell Multi-Omics Major Product Offerings
7.4.4 Bio-Rad Laboratories Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.4.5 Bio-Rad Laboratories Key News & Latest Developments
7.5 Celsee
7.5.1 Celsee Company Summary
7.5.2 Celsee Business Overview
7.5.3 Celsee Human Single-Cell Multi-Omics Major Product Offerings
7.5.4 Celsee Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.5.5 Celsee Key News & Latest Developments
7.6 Fluidigm Corporation
7.6.1 Fluidigm Corporation Company Summary
7.6.2 Fluidigm Corporation Business Overview
7.6.3 Fluidigm Corporation Human Single-Cell Multi-Omics Major Product Offerings
7.6.4 Fluidigm Corporation Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.6.5 Fluidigm Corporation Key News & Latest Developments
7.7 Fluxion Biosciences
7.7.1 Fluxion Biosciences Company Summary
7.7.2 Fluxion Biosciences Business Overview
7.7.3 Fluxion Biosciences Human Single-Cell Multi-Omics Major Product Offerings
7.7.4 Fluxion Biosciences Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.7.5 Fluxion Biosciences Key News & Latest Developments
7.8 MissionBio
7.8.1 MissionBio Company Summary
7.8.2 MissionBio Business Overview
7.8.3 MissionBio Human Single-Cell Multi-Omics Major Product Offerings
7.8.4 MissionBio Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.8.5 MissionBio Key News & Latest Developments
7.9 NanoString Technologies
7.9.1 NanoString Technologies Company Summary
7.9.2 NanoString Technologies Business Overview
7.9.3 NanoString Technologies Human Single-Cell Multi-Omics Major Product Offerings
7.9.4 NanoString Technologies Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.9.5 NanoString Technologies Key News & Latest Developments
7.10 Takara Bio
7.10.1 Takara Bio Company Summary
7.10.2 Takara Bio Business Overview
7.10.3 Takara Bio Human Single-Cell Multi-Omics Major Product Offerings
7.10.4 Takara Bio Human Single-Cell Multi-Omics Revenue in Global Market (2018-2023)
7.10.5 Takara Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com